press releases 2021
Croma-Pharma Announces 9-Country Licensing Agreement with Crescita Therapeutics for Pliaglis®
Croma-Pharma presents new cosmetic skincare brand „Croma farewell™“ for common skin conditions
2020
Croma establishes new joint venture in China
Croma-Pharma GmbH expands its portfolio introducing pure HA
Croma-Pharma announces submission for their botulinum toxin to treat glabellar (frown) lines to the German authority BfArM
BVI forges strategic partnership with Croma-Pharma
Croma-Pharma supports Light for the World
2019
Croma-Pharma GmbH establishes affiliate in UK
Croma-Pharma reveals new packaging design for the Arthrex ACP® double syringe system
Croma-Pharma GmbH expands its portfolio introducing elure
2018
Croma-Pharma: „Made in Austria“ – with minimally invasive aesthetic medicine (MIAM) becoming a global player
Leobendorf, March 2018 – Croma-Pharma GmbH, or Croma for short, is an international pharmaceutical company based in Leobendorf, Austria. For over 40 years, innovative drugs and medical devices for the fields of ophthalmology, orthopedics and aesthetic dermatology have been developed and produced. Thus, Croma has made important contributions to improving health and quality of life for four decades.
picture downloads
Mag. Pharm Gerhard Prinz
Mag. Pharm Andreas Prinz
Mag. Pharm Martin Prinz
Prince Family Group Photo
Croma Headquarters Leobendorf
Management Board Croma-Pharma
